Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Dent Res ; 100(10): 1109-1117, 2021 09.
Article in English | MEDLINE | ID: mdl-34334009

ABSTRACT

To establish an ideal microenvironment for regenerating maxillofacial defects, recent research interests have concentrated on developing scaffolds with intricate configurations and manipulating the stiffness of extracellular matrix toward osteogenesis. Herein, we propose to infuse a degradable RGD-functionalized alginate matrix (RAM) with osteoid-like stiffness, as an artificial extracellular matrix, to a rigid 3D-printed hydroxyapatite scaffold for maxillofacial regeneration. The 3D-printed hydroxyapatite scaffold was produced by microextrusion technology and showed good dimensional stability with consistent microporous detail. RAM was crosslinked by calcium sulfate to manipulate the stiffness, and its degradation was accelerated by partial oxidation using sodium periodate. The results revealed that viability of bone marrow stem cells was significantly improved on the RAM and was promoted on the oxidized RAM. In addition, the migration and osteogenic differentiation of bone marrow stem cells were promoted on the RAM with osteoid-like stiffness, specifically on the oxidized RAM. The in vivo evidence revealed that nonoxidized RAM with osteoid-like stiffness upregulated osteogenic genes but prevented ingrowth of newly formed bone, leading to limited regeneration. Oxidized RAM with osteoid-like stiffness facilitated collagen synthesis, angiogenesis, and osteogenesis and induced robust bone formation, thereby significantly promoting maxillofacial regeneration. Overall, this study supported that in the stabilized microenvironment, oxidized RAM with osteoid-like stiffness offered requisite mechanical cues for osteogenesis and an appropriate degradation profile to facilitate bone formation. Combining the 3D-printed hydroxyapatite scaffold and oxidized RAM with osteoid-like stiffness may be an advantageous approach for maxillofacial regeneration.


Subject(s)
Osteogenesis , Tissue Scaffolds , Bone Regeneration , Cell Differentiation , Oligopeptides , Printing, Three-Dimensional
2.
J Appl Microbiol ; 122(3): 770-784, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28004480

ABSTRACT

AIMS: To investigate the in vivo effects of Lactobacillus rhamnosus GG (LGG) on intestinal polyp development and the interaction between this single-organism probiotic and the gut microbiota therein. METHODS AND RESULTS: The ApcMin/+ mouse model was used to study the potential preventive effect of LGG on intestinal polyposis, while shotgun metagenomic sequencing was employed to characterize both taxonomic and functional changes within the gut microbial community. We found that the progression of intestinal polyps in the control group altered the community functional profile remarkably despite small variation in the taxonomic diversity. In comparison, the consumption of LGG helped maintain the overall functional potential and taxonomic profile in the resident microbes, thereby leading to a 25% decrease of total polyp counts. Furthermore, we found that LGG enriched those microbes or microbial activities related to short-chain fatty acid production (e.g. Roseburia and Coprococcus), as well as suppressed the ones that can lead to inflammation (e.g. Bilophila wadsworthia). CONCLUSIONS: Our study using shotgun metagenomics highlights how single probiotic LGG may exert its beneficial effects and decrease polyp formation in mice by maintaining gut microbial functionality. SIGNIFICANCE AND IMPACT OF THE STUDY: This probiotic intervention targeting microbiota may be used in conjugation with other dietary supplements or drugs as part of prevention strategies for early-stage colon cancer, after further clinical validations in human.


Subject(s)
Intestinal Polyps/prevention & control , Lacticaseibacillus rhamnosus/growth & development , Microbiota/drug effects , Probiotics/therapeutic use , Sulindac/therapeutic use , Adenomatous Polyposis Coli Protein/genetics , Animals , Humans , Metagenomics/methods , Mice , Phylogeny , Probiotics/pharmacology , Specific Pathogen-Free Organisms , Sulindac/pharmacology
3.
Tech Coloproctol ; 19(2): 111-5, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25560967

ABSTRACT

BACKGROUND: It could be helpful to ascertain which patients are at risk of poor bowel preparation prior to performing sedated colonoscopy. The aim of the present study was to identify the predictive factors for poor colon preparation prior to colonoscopy. METHODS: A prospective study was performed at Kaohsiung Chang Gung Memorial Hospital, Taiwan, from September 2011 to May 2013. Patient characteristics, food consumed within 2 days of colonoscopy, volume of polyethylene glycol (PEG) solution, interval between completing PEG and examination, number of bowel movements, and character of the last stool were evaluated. RESULTS: Seven hundred and three patients were enrolled (mean age 50.3 ± 11.6 years, 43 % female). In univariate analysis, character of the last stool (<0.001), body weight (p = 0.007), body mass index (p = 0.047), waist circumference (p = 0.008), buttock girth (p = 0.016), meal residue score (<0.001), and interval between end of PEG and colonoscopy (p = 0.01) were related to inadequate colon preparation. In multivariate analysis, waist circumference (p < 0.001), meal residue score (p < 0.001), and characteristics of last stool (p < 0.001) were variables that predicted poor colon preparation. CONCLUSIONS: Patients who have consumed a high residue diet and/or who report that their last stool is semisolid are likely to have poor bowel preparation, and consideration could be given to rescheduling the examination.


Subject(s)
Colonoscopy , Preoperative Care/standards , Adult , Analysis of Variance , Cathartics/administration & dosage , Defecation , Diet/adverse effects , Eating , Feces/chemistry , Female , Humans , Male , Middle Aged , Polyethylene Glycols/administration & dosage , Preoperative Care/methods , Preoperative Care/statistics & numerical data , Prospective Studies , Risk Factors , Taiwan , Time Factors
4.
Int J Clin Pract ; 66(8): 774-781, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22650364

ABSTRACT

Background and Aims: Patients suffering from peptic ulcer (PU) bleeding who have end-stage renal disease (ESRD) may encounter more adverse outcomes. The primary objective is to investigate the risk factors that influence the outcomes of ESRD and chronic kidney disease (CKD) patients with PU bleeding after successful initial endoscopic haemostasis. Methods: A total of 540 patients with PU bleeding after initial endoscopic haemostasis in a tertiary hospital were investigated retrospectively. They were sorted into three groups after randomised age-matched adjustment: ESRD group (n = 90), CKD group (n = 90) and control group (n = 360). Main outcome measurements were rebleeding, requirement for blood transfusion and surgery, length of hospital stay and mortality. Results: The rebleeding rates were 43% for the ESRD group vs. 21% for the CKD group vs. 12% for the control group (overall p = < 0.001). Multivariate analysis showed the predictors of rebleeding were ESRD, time to endoscope, and non-high-dose proton-pump inhibitors (PPI) users. The risk factors for bleeding-related mortality were presence of moderate degree of CKD and ESRD group, time to endoscope, and Rockall score. All-cause mortality was related to presence of moderate degree of CKD and ESRD group, platelet count, time to endoscope, Rockall score and length of hospital stay. Conclusions: ESRD patients who suffered from PU bleeding were at risk of excessive rebleeding and mortality with frequent occurrence of delayed rebleeding. This study suggests that early endoscopy for initial haemostasis and high-dose intravenous PPI are associated with the reduction of rebleeding risk especially in patients with high Rockall scores.

5.
Colorectal Dis ; 12(7 Online): e114-20, 2010 Jul.
Article in English | MEDLINE | ID: mdl-19832872

ABSTRACT

OBJECTIVE: Ano-perianal tuberculosis (TB) is a rare extrapulmonary form of the disease. Most publications are in case report form. We report our cohort retrospective study on ano-perianal TB, which is one of the very few original reports in the literature. METHOD: Over a period of 15 years (January 1992-December 2006), file records revealed cases with confirmed diagnosis of ano-perianal TB after screening from a total of 1251 patients with the diagnosis of TB from Chang Gung Memorial Hospital-Kaohsiung, Taiwan. RESULTS: This study recruited 17 patients (14 male patients and 3 female patients). The age ranged from 18 to 81 years with a mean age of 44.8 +/- 18.2 years. Thirteen patients had coexistent pulmonary TB (76.5%). Eight patients had at least one concomitant co-morbid illness (47.1%). The most common clinical manifestations were anal fistulae (n = 16). All patients who completed a full course of anti-mycobacterial treatment for at least 6 months after surgical intervention were cured without recurrence except for one patient who was lost to follow-up after 2 months of treatment. Seven of the nine patients with complicated fistulae needed longer anti-mycobacterium treatment duration (9-18 months). CONCLUSION: Ano-perianal TB should be kept in mind for all patients with prolonged or repeatedly recurrent ano-perianal symptoms and signs such as complicated fistulae in an endemic TB area like Taiwan. Management strategy is with conventional anti-mycobacterium therapy for at least 6 months after surgery. An extension of the anti-mycobacterium treatment course to 9-18 months is mandatory for patients with complicated disease presentations.


Subject(s)
Anal Canal/microbiology , Anus Diseases/epidemiology , Mycobacterium tuberculosis/isolation & purification , Tuberculosis, Gastrointestinal/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Anal Canal/pathology , Anus Diseases/diagnosis , Anus Diseases/microbiology , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Retrospective Studies , Taiwan/epidemiology , Time Factors , Tuberculosis, Gastrointestinal/diagnosis , Tuberculosis, Gastrointestinal/microbiology , Young Adult
7.
Clin Exp Dermatol ; 34(8): e927-30, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20055869

ABSTRACT

Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTLN), is characterized by higher prevalence in East Asians and South Americans, association with Epstein-Barr virus infection, aggressive nature in most cases, and resistance to conventional treatment strategies such as chemotherapy and radiotherapy. The optimum treatment for this disease has not yet been established. We report a successful treatment experience in a case of ENKTLN, with a combination regimen including interferon-alpha, corticosteroid and narrowband ultraviolet B, which may serve as a promising therapy for this aggressive disease at earlier stages.


Subject(s)
Interferon-alpha/administration & dosage , Lymphoma, T-Cell/therapy , Nose Neoplasms/therapy , Combined Modality Therapy , Female , Humans , Lymphoma, T-Cell/pathology , Middle Aged , Natural Killer T-Cells/pathology , Nose Neoplasms/pathology , Phototherapy , Treatment Outcome
8.
FEBS Lett ; 500(3): 177-82, 2001 Jul 06.
Article in English | MEDLINE | ID: mdl-11445081

ABSTRACT

SNAREs are membrane-associated proteins that play a central role in vesicle targeting and intra-cellular membrane fusion reactions in eukaryotic cells. Here we describe the identification of AtBS14a and AtBS14b, putative SNAREs from Arabidopsis thaliana that share 60% amino acid sequence identity. Both AtBS14a and BS14b are dosage suppressors of the temperature-sensitive growth defect in sft1-1 cells and over-expression of either AtBS14a or AtBS14b can support the growth of sft1Delta cells but not bet1Delta cells. These data together with structure-function and biochemical studies presented herein suggest that AtBS14a and AtBS14b share properties that are consistent with them being members of the Bet1/Sft1 SNARE protein family.


Subject(s)
Arabidopsis Proteins , Arabidopsis/genetics , Membrane Proteins/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Vesicular Transport Proteins , Arabidopsis/metabolism , Cell Division/physiology , Genetic Complementation Test , Golgi Apparatus/metabolism , Intracellular Membranes/metabolism , Intracellular Membranes/ultrastructure , Membrane Proteins/metabolism , Molecular Sequence Data , Multigene Family , Mutation , Plant Proteins/genetics , Plant Proteins/metabolism , Qc-SNARE Proteins , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , SNARE Proteins , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/ultrastructure , Sequence Homology, Amino Acid , Temperature , Transformation, Genetic
9.
Mol Biol Cell ; 12(3): 521-38, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11251068

ABSTRACT

Sed5p is the only syntaxin family member required for protein transport through the yeast Golgi and it is known to bind up to nine other soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) proteins in vivo. We describe in vitro binding experiments in which we identify ternary and quaternary Sed5p-containing SNARE complexes. The formation of SNARE complexes among these endoplasmic reticulum- and Golgi-localized proteins requires Sed5p and is syntaxin-selective. In addition, Sed5p-containing SNARE complexes form selectively and this selectivity is mediated by Sed5p-containing intermediates that discriminate among subsequent binding partners. Although many of these SNAREs have overlapping distributions in vivo, the SNAREs that form complexes with Sed5p in vitro reflect their functionally distinct locales. Although SNARE-SNARE interactions are promiscuous and a single SNARE protein is often found in more than one complex, both the biochemical as well as genetic analyses reported here suggest that this is not a result of nonselective direct substitution of one SNARE for another. Rather our data are consistent with the existence of multiple (perhaps parallel) trafficking pathways where Sed5p-containing SNARE complexes play overlapping and/or distinct functional roles.


Subject(s)
Fungal Proteins/metabolism , Membrane Proteins/metabolism , Saccharomyces cerevisiae Proteins , Vesicular Transport Proteins , Amino Acid Sequence , Biological Transport, Active , Carrier Proteins/chemistry , Carrier Proteins/genetics , Carrier Proteins/metabolism , Fungal Proteins/chemistry , Fungal Proteins/genetics , Golgi Apparatus/metabolism , Macromolecular Substances , Membrane Proteins/chemistry , Membrane Proteins/genetics , Microscopy, Electron , Molecular Sequence Data , Qa-SNARE Proteins , Qb-SNARE Proteins , R-SNARE Proteins , SNARE Proteins , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae/ultrastructure , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...